CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 30547-30884 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T182","span":{"begin":0,"end":337},"obj":"Sentence"},{"id":"T7296","span":{"begin":0,"end":337},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Compounds 101, 102 and 103 ( Fig. 9 ) displayed the most potent protective potency against pentylenetetrazole (PTZ)-induced clonic seizures in mice at a dosage level of 20 mg/kg with the protective ratio for 74.5, 78.7 and 74%, respectively, which was close to phenobarbital sodium (30 mg/kg) and better than phenytoin sodium (30 mg/kg)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T182","span":{"begin":0,"end":337},"obj":"Sentence"}],"text":"Compounds 101, 102 and 103 ( Fig. 9 ) displayed the most potent protective potency against pentylenetetrazole (PTZ)-induced clonic seizures in mice at a dosage level of 20 mg/kg with the protective ratio for 74.5, 78.7 and 74%, respectively, which was close to phenobarbital sodium (30 mg/kg) and better than phenytoin sodium (30 mg/kg)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T31","span":{"begin":124,"end":139},"obj":"Phenotype"},{"id":"T32","span":{"begin":131,"end":139},"obj":"Phenotype"}],"attributes":[{"id":"A31","pred":"hp_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/HP_0020221"},{"id":"A32","pred":"hp_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/HP_0001250"}],"text":"Compounds 101, 102 and 103 ( Fig. 9 ) displayed the most potent protective potency against pentylenetetrazole (PTZ)-induced clonic seizures in mice at a dosage level of 20 mg/kg with the protective ratio for 74.5, 78.7 and 74%, respectively, which was close to phenobarbital sodium (30 mg/kg) and better than phenytoin sodium (30 mg/kg)."}